Dbv technologies to participate in upcoming investor conferences

Montrouge, france, may 9, 2024 dbv technologies to participate in upcoming investor conferences dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced daniel tassÉ, chief executive officer, will deliver a company presentation at two investor conferences in may. citizens jmp life sciences conference – may 13, 2024 format:         fireside chat time:             11:00am etlocation:       hilton midtown hotel, new york, ny h.c.
DBVT Ratings Summary
DBVT Quant Ranking